All peptides
Melanotan-1

Melanotan-1

Melanotan-1 is the compound behind afamelanotide, which holds marketing authorisation as Scenesse for a rare light-sensitivity condition and is...

About:

An alpha-MSH analogue approved as afamelanotide for erythropoietic protoporphyria and sold separately as a tanning peptide.

Skin & Anti-AgingImplant or lyophilized vial

What does this peptide do?

Backed by human trial data, narrower than the strongest evidence. Research focuses on erythropoietic protoporphyria and tanning.

Erythropoietic protoporphyria

Approved as afamelanotide for erythropoietic protoporphyria.

Tanning

Sold separately, unlicensed, as a tanning peptide.

Evidence grade

B

Highest evidence grade among the graded claims: B. Grades reflect study strength, not benefit.

What are the benefits and side effects of this peptide

What research says it may help with

  • Randomized studies support light tolerance outcomes there.

Who should avoid it

  • People who are pregnant or breastfeeding
  • Children and adolescents
  • People with many moles or a history of skin cancer
  • Known hypersensitivity to peptide preparations
  • Personal or family history of melanoma or atypical moles

See the safety section. Absence of a flag is not evidence of safety.

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.

How to store this peptide

The licensed form is a controlled-release implant placed by a clinician. Research-market powder is perishable once reconstituted and requires refrigeration and clean handling.

Lyophilized storage

Refrigerate at 2–8 °C in the original carton. Do not freeze.

Reconstituted storage

Once in use, may be kept below 30 °C for the period stated on the product label.

Storage Handling

Protect from light. Do not use if it has been frozen.

Related research

Related research is coming soon for this peptide.

Related peptides

Save hours, stay ahead, and join the elite 1% who prioritize their wellness with science-backed knowledge in minutes.

By clicking Subscribe, you agree to receive MaxHuman research summaries by email. Unsubscribe anytime.

Trusted by 1,525 readers